Matching articles for "artificial pancreas"
Minimed 670G: A Hybrid Closed-Loop Insulin Delivery System
The Medical Letter on Drugs and Therapeutics • November 21, 2016; (Issue 1508)
The FDA has approved the Minimed 670G (Medtronic),
a hybrid closed-loop insulin delivery system for use in
patients ≥14 years old with type 1 diabetes. The system
uses an algorithm to automatically adjust...
The FDA has approved the Minimed 670G (Medtronic),
a hybrid closed-loop insulin delivery system for use in
patients ≥14 years old with type 1 diabetes. The system
uses an algorithm to automatically adjust basal insulin
doses based on readings from a continuous glucose
monitor (CGM). It fully automates basal insulin
delivery in "auto" mode, but is considered a "hybrid"
system (not a true "artificial pancreas") because it
requires some action by the patient. The 670G system
is expected to become available in Spring 2017.
MiniMed 530G: An Insulin Pump with Low-Glucose Suspend Automation
The Medical Letter on Drugs and Therapeutics • December 9, 2013; (Issue 1431)
The FDA has approved the MiniMed 530G
(Medtronic), an insulin pump used in combination with
a continuous glucose monitoring sensor (Enlite) that
can stop delivery of insulin when interstitial...
The FDA has approved the MiniMed 530G
(Medtronic), an insulin pump used in combination with
a continuous glucose monitoring sensor (Enlite) that
can stop delivery of insulin when interstitial glucose
reaches a prespecified low level. It is the only sensoraugmented
insulin pump available in the US with this
capability.